FDA Adverse Event Death Summary report: N

UNKNOWN ENDO GIA SULU

MDR report key: 19817273 · Received July 24, 2024

Report

Report Number
2647580-2024-03216
Event Type
Death
Date Received
July 24, 2024
Date of Event
March 8, 2024
Report Date
July 24, 2024
Manufacturer
US SURGICAL PUERTO RICO
Product Code
GDW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MÜMIN COSKUN MD, TEVFIK KIVILCIM UPRAK MD, ÖMER GÜNAL MD, AYGÜN ALIYEVA MD, AND ASIM CINGI MD. REINFORCEMENT IN LAPAROSCOPIC SLEEVE GASTRECTOMY: IS IT EFFECTIVE? SURGICAL LAPAROSCOPY, ENDOSCOPY <(>&<)> PERCUTANEOUS TECHNIQUES 34(3):P 290-294, JUNE 2024. DOI: 10.1 097/SLE.0000000000001283. PMID: 38736400. D10 CONCOMITANT PRODUCTS: UNKNOWN EGIA SU, UNKNOWN ENDO GIA SULU, (LOT# UNKNOWN) UNKNOWN-VLOC, UNKNOWN VLOC PRODUCT, (LOT# UNKNOWN) UNKNOWN LIGASUR, UNKNOWN LIGASURE INSTRUMENT, (LOT# UNKNOWN) 173022, 173022 ENDO CLOSE, (LOT# UNKNOWN) UNKNOWN LIGASUR, UNKNOWN LIGASURE INSTRUMENT, (LOT# UNKNOWN) UNKNOWN EGIA SU, UNKNOWN ENDO GIA SULU, (LOT# UNKNOWN). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

ACCORDING TO THE LITERATURE, A RETROSPECTIVE STUDY EXAMINED STAPLER LINE REINFORCEMENT AND ITS ASSOCIATION WITH POSTOPERATIVE LEAKAGE AND BLEEDING RATES IN PATIENTS WHO UNDERWENT LAPAROSCOPIC SLEEVE GASTRECTOMY BETWEEN 2011 AND 2018. THERE WERE 286 PATIENTS IN THE REINFORCEMENT GROUP AND 224 IN THE NONREINFORCEMENT GROUP. IN ALL PATIENTS THE 60MM RELOAD OR A COMPETITOR DEVICE WAS USED FOR GASTRIC RESECTION. LEAKS WERE DIAGNOSED USING COMPUTED TOMOGRAPHY (CT) OR AN UPPER GASTROINTESTINAL RADIOGRAPH. POSTOPERATIVE COMPLICATIONS INCLUDED STAPLE LINE LEAKS, BLEEDING AND TROCAR SITE HERNIA. THERE WERE TWO LEAKS IN THE REINFORCEMENT GROUP THAT WERE TREATED WITH SELF-EXPANDABLE METALLIC STENTS AND CT-GUIDED DRAINAGE. THERE WERE NINE LEAKS IN THE NONREINFORCEMENT GROUP. THREE PATIENTS WERE SUCCESSFULLY TREATED WITH LAPAROSCOPY, PRIMARY SUTURE OF THE LEAK SITE COMBINED WITH STENT PLACEMENT, AND DRAINAGE THE DAY AFTER SURGERY. THE OTHER SIX LEAKS WERE TREATED WITH LAPAROTOMY DRAINAGE AND STENT PLACEMENT. TWO OF THESE SIX PATIENTS DIED. POSTOPERATIVE BLEEDING WAS TREATED CONSERVATIVELY IN THE REINFORCED GROUP AND WITH ADDITIONAL SURGERY OR TREATED CONSERVATIVELY IN THE NONREINFORCED GROUP. EXTENDED HOSPITAL STAY AND READMISSIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2370603 UNKNOWN ENDO GIA SULU STAPLE, IMPLANTABLE GDW US SURGICAL PUERTO RICO UNKNOWN ENDO GIA SULU

Patients

Seq Age Sex Outcome Treatment
1 39 YR Female Death| R| O| H